{"entity":{"type":"insider","cik":"0001916048","url":"/insider/0001916048","json_url":"/insider/0001916048.json","name":"Warren Eric","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":30,"n_filings":30,"first":"2022-05-18","last":"2026-08-25","span_basis":"filed_date"},"name_variants":[{"name":"Warren Eric","source":"filing","n_filings":30,"first_seen":"2022-05-18","last_seen":"2026-08-25"}],"transactions":[{"id":9301251,"accession":"0001916048-26-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001916048-26-000012","line_url":"/filing/0001916048-26-000012#line-1","is_derivative":false,"issuer_cik":"0001933414","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001933414","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7437.0,"shares_display":"7,437","price_per_share":25.9767,"price_display":"25.98","price_state":"stated","total_value":193188.7179,"total_display":"193,188.72","total_whole":"193,189","shares_owned_after":38400.0,"shares_owned_after_display":"38,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-21","filed_date":"2026-08-25","scope":"insider"},{"id":5997881,"accession":"0001916048-26-000009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001916048-26-000009","line_url":"/filing/0001916048-26-000009#line-2","is_derivative":false,"issuer_cik":"0001916048","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001916048","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7438.0,"shares_display":"7,438","price_per_share":26.8735,"price_display":"26.87","price_state":"stated","total_value":199885.093,"total_display":"199,885.09","total_whole":"199,885","shares_owned_after":38400.0,"shares_owned_after_display":"38,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-21","filed_date":"2026-07-23","scope":"insider"},{"id":5852882,"accession":"0001933414-26-000095","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001933414-26-000095","line_url":"/filing/0001933414-26-000095#line-2","is_derivative":false,"issuer_cik":"0001916048","issuer_name":"Mineralys Therapeutics, Inc.","issuer_ticker":"MLYS","issuer_name_source":null,"issuer_url":"/issuer/0001916048","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":104124.0,"shares_display":"104,124","price_per_share":25.8953,"price_display":"25.90","price_state":"stated","total_value":2696322.2172,"total_display":"2,696,322.22","total_whole":"2,696,322","shares_owned_after":38400.0,"shares_owned_after_display":"38,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":4503458,"accession":"0001628280-25-018567","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-018567","line_url":"/filing/0001628280-25-018567#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":108.0,"shares_display":"108","price_per_share":0.978,"price_display":"0.98","price_state":"stated","total_value":105.624,"total_display":"105.62","total_whole":"106","shares_owned_after":370218.0,"shares_owned_after_display":"370,218","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-17","filed_date":"2025-04-21","scope":"insider"},{"id":4046626,"accession":"0001628280-25-013811","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-013811","line_url":"/filing/0001628280-25-013811#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2433.0,"shares_display":"2,433","price_per_share":1.487,"price_display":"1.49","price_state":"stated","total_value":3617.871,"total_display":"3,617.87","total_whole":"3,618","shares_owned_after":370326.0,"shares_owned_after_display":"370,326","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-18","filed_date":"2025-03-19","scope":"insider"},{"id":4148121,"accession":"0001628280-25-006802","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-006802","line_url":"/filing/0001628280-25-006802#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":239.0,"shares_display":"239","price_per_share":1.868,"price_display":"1.87","price_state":"stated","total_value":446.452,"total_display":"446.45","total_whole":"446","shares_owned_after":159759.0,"shares_owned_after_display":"159,759","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-20","scope":"insider"},{"id":5094392,"accession":"0001628280-25-002035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-002035","line_url":"/filing/0001628280-25-002035#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":123.0,"shares_display":"123","price_per_share":2.26,"price_display":"2.26","price_state":"stated","total_value":277.98,"total_display":"277.98","total_whole":"278","shares_owned_after":159998.0,"shares_owned_after_display":"159,998","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-17","filed_date":"2025-01-21","scope":"insider"},{"id":2491470,"accession":"0001628280-24-051870","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-051870","line_url":"/filing/0001628280-24-051870#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2234.0,"shares_display":"2,234","price_per_share":2.429,"price_display":"2.43","price_state":"stated","total_value":5426.386,"total_display":"5,426.39","total_whole":"5,426","shares_owned_after":160121.0,"shares_owned_after_display":"160,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-17","filed_date":"2024-12-18","scope":"insider"},{"id":2830351,"accession":"0001628280-24-048659","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-048659","line_url":"/filing/0001628280-24-048659#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":197.0,"shares_display":"197","price_per_share":2.165,"price_display":"2.16","price_state":"stated","total_value":426.505,"total_display":"426.50","total_whole":"427","shares_owned_after":162355.0,"shares_owned_after_display":"162,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-19","filed_date":"2024-11-20","scope":"insider"},{"id":2922751,"accession":"0001628280-24-043107","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-043107","line_url":"/filing/0001628280-24-043107#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":107.0,"shares_display":"107","price_per_share":2.119,"price_display":"2.12","price_state":"stated","total_value":226.733,"total_display":"226.73","total_whole":"227","shares_owned_after":162552.0,"shares_owned_after_display":"162,552","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-17","filed_date":"2024-10-18","scope":"insider"},{"id":2326203,"accession":"0001628280-24-040785","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-040785","line_url":"/filing/0001628280-24-040785#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2608.0,"shares_display":"2,608","price_per_share":1.783,"price_display":"1.78","price_state":"stated","total_value":4650.064,"total_display":"4,650.06","total_whole":"4,650","shares_owned_after":162659.0,"shares_owned_after_display":"162,659","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-17","filed_date":"2024-09-18","scope":"insider"},{"id":2123362,"accession":"0001628280-24-037887","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-037887","line_url":"/filing/0001628280-24-037887#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":211.0,"shares_display":"211","price_per_share":1.946,"price_display":"1.95","price_state":"stated","total_value":410.606,"total_display":"410.61","total_whole":"411","shares_owned_after":165267.0,"shares_owned_after_display":"165,267","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-19","filed_date":"2024-08-20","scope":"insider"},{"id":2648127,"accession":"0001628280-24-032268","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-032268","line_url":"/filing/0001628280-24-032268#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":108.0,"shares_display":"108","price_per_share":2.587,"price_display":"2.59","price_state":"stated","total_value":279.396,"total_display":"279.40","total_whole":"279","shares_owned_after":165478.0,"shares_owned_after_display":"165,478","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-17","filed_date":"2024-07-19","scope":"insider"},{"id":3187063,"accession":"0001628280-24-029114","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-029114","line_url":"/filing/0001628280-24-029114#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2540.0,"shares_display":"2,540","price_per_share":2.856,"price_display":"2.86","price_state":"stated","total_value":7254.24,"total_display":"7,254.24","total_whole":"7,254","shares_owned_after":165586.0,"shares_owned_after_display":"165,586","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-18","filed_date":"2024-06-20","scope":"insider"},{"id":2259782,"accession":"0001628280-24-024346","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-024346","line_url":"/filing/0001628280-24-024346#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":192.0,"shares_display":"192","price_per_share":2.483,"price_display":"2.48","price_state":"stated","total_value":476.736,"total_display":"476.74","total_whole":"477","shares_owned_after":168126.0,"shares_owned_after_display":"168,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-17","filed_date":"2024-05-20","scope":"insider"},{"id":8088743,"accession":"0001628280-23-032795","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-032795","line_url":"/filing/0001628280-23-032795#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":742.0,"shares_display":"742","price_per_share":1.245,"price_display":"1.24","price_state":"stated","total_value":923.79,"total_display":"923.79","total_whole":"924","shares_owned_after":68318.0,"shares_owned_after_display":"68,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-20","filed_date":"2023-09-21","scope":"insider"},{"id":7935856,"accession":"0001628280-23-030129","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-030129","line_url":"/filing/0001628280-23-030129#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":243.0,"shares_display":"243","price_per_share":1.414,"price_display":"1.41","price_state":"stated","total_value":343.602,"total_display":"343.60","total_whole":"344","shares_owned_after":69060.0,"shares_owned_after_display":"69,060","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-18","filed_date":"2023-08-21","scope":"insider"},{"id":8025370,"accession":"0001628280-23-025248","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-025248","line_url":"/filing/0001628280-23-025248#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":106.0,"shares_display":"106","price_per_share":1.585,"price_display":"1.58","price_state":"stated","total_value":168.01,"total_display":"168.01","total_whole":"168","shares_owned_after":69303.0,"shares_owned_after_display":"69,303","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-19","filed_date":"2023-07-20","scope":"insider"},{"id":8639606,"accession":"0001628280-23-023157","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-023157","line_url":"/filing/0001628280-23-023157#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":603.0,"shares_display":"603","price_per_share":1.483,"price_display":"1.48","price_state":"stated","total_value":894.249,"total_display":"894.25","total_whole":"894","shares_owned_after":69409.0,"shares_owned_after_display":"69,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-21","filed_date":"2023-06-22","scope":"insider"},{"id":8047346,"accession":"0001628280-23-018872","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-018872","line_url":"/filing/0001628280-23-018872#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":219.0,"shares_display":"219","price_per_share":1.624,"price_display":"1.62","price_state":"stated","total_value":355.656,"total_display":"355.66","total_whole":"356","shares_owned_after":70012.0,"shares_owned_after_display":"70,012","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-17","filed_date":"2023-05-18","scope":"insider"},{"id":8616942,"accession":"0001628280-23-012265","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-012265","line_url":"/filing/0001628280-23-012265#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":115.0,"shares_display":"115","price_per_share":1.278,"price_display":"1.28","price_state":"stated","total_value":146.97,"total_display":"146.97","total_whole":"147","shares_owned_after":70231.0,"shares_owned_after_display":"70,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-19","filed_date":"2023-04-20","scope":"insider"},{"id":8306102,"accession":"0001628280-23-008609","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-008609","line_url":"/filing/0001628280-23-008609#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":526.0,"shares_display":"526","price_per_share":1.7823,"price_display":"1.78","price_state":"stated","total_value":937.4898,"total_display":"937.49","total_whole":"937","shares_owned_after":70346.0,"shares_owned_after_display":"70,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-17","filed_date":"2023-03-20","scope":"insider"},{"id":8408446,"accession":"0001628280-23-006992","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-006992","line_url":"/filing/0001628280-23-006992#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5090.0,"shares_display":"5,090","price_per_share":5.055,"price_display":"5.06","price_state":"stated","total_value":25729.95,"total_display":"25,729.95","total_whole":"25,730","shares_owned_after":48572.0,"shares_owned_after_display":"48,572","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-07","filed_date":"2023-03-08","scope":"insider"},{"id":6190237,"accession":"0001628280-22-026631","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-026631","line_url":"/filing/0001628280-22-026631#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":107.0,"shares_display":"107","price_per_share":7.69,"price_display":"7.69","price_state":"stated","total_value":822.83,"total_display":"822.83","total_whole":"823","shares_owned_after":53662.0,"shares_owned_after_display":"53,662","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-18","filed_date":"2022-10-19","scope":"insider"},{"id":6635318,"accession":"0001628280-22-025218","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-025218","line_url":"/filing/0001628280-22-025218#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":255.0,"shares_display":"255","price_per_share":6.921,"price_display":"6.92","price_state":"stated","total_value":1764.855,"total_display":"1,764.86","total_whole":"1,765","shares_owned_after":53769.0,"shares_owned_after_display":"53,769","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-19","filed_date":"2022-09-20","scope":"insider"},{"id":6635276,"accession":"0001628280-22-024059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-024059","line_url":"/filing/0001628280-22-024059#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":7.46,"price_display":"7.46","price_state":"stated","total_value":7460.0,"total_display":"7,460.00","total_whole":"7,460","shares_owned_after":54024.0,"shares_owned_after_display":"54,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-31","filed_date":"2022-08-31","scope":"insider"},{"id":6939858,"accession":"0001628280-22-023250","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-023250","line_url":"/filing/0001628280-22-023250#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":199.0,"shares_display":"199","price_per_share":6.815,"price_display":"6.82","price_state":"stated","total_value":1356.185,"total_display":"1,356.18","total_whole":"1,356","shares_owned_after":53024.0,"shares_owned_after_display":"53,024","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-17","filed_date":"2022-08-18","scope":"insider"},{"id":6524476,"accession":"0001628280-22-019179","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-019179","line_url":"/filing/0001628280-22-019179#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":431.0,"shares_display":"431","price_per_share":6.582,"price_display":"6.58","price_state":"stated","total_value":2836.842,"total_display":"2,836.84","total_whole":"2,837","shares_owned_after":53223.0,"shares_owned_after_display":"53,223","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-19","filed_date":"2022-07-20","scope":"insider"},{"id":6763232,"accession":"0001628280-22-017640","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-017640","line_url":"/filing/0001628280-22-017640#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":256.0,"shares_display":"256","price_per_share":4.9,"price_display":"4.90","price_state":"stated","total_value":1254.4,"total_display":"1,254.40","total_whole":"1,254","shares_owned_after":53654.0,"shares_owned_after_display":"53,654","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-17","filed_date":"2022-06-21","scope":"insider"},{"id":6635156,"accession":"0001628280-22-014762","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-22-014762","line_url":"/filing/0001628280-22-014762#line-1","is_derivative":false,"issuer_cik":"0001434868","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001434868","owner_cik":"0001916048","owner_name":"Warren Eric","owner_display_name":"Warren Eric","owner_url":"/insider/0001916048","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":196.0,"shares_display":"196","price_per_share":5.981,"price_display":"5.98","price_state":"stated","total_value":1172.276,"total_display":"1,172.28","total_whole":"1,172","shares_owned_after":53910.0,"shares_owned_after_display":"53,910","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-17","filed_date":"2022-05-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":30,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":29,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":30},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001933414","name":"Mineralys Therapeutics, Inc.","url":"/issuer/0001933414","role":"Officer (Chief Commercial Officer)","n_filings":3,"first_seen":"2026-06-30","last_seen":"2026-08-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001434868","name":"Esperion Therapeutics, Inc.","url":"/issuer/0001434868","role":"Officer (Chief Commercial Officer)","n_filings":27,"first_seen":"2022-05-18","last_seen":"2025-04-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001916048","retrieved_at":"2026-08-26T20:57:32+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}